Harmony Biosciences Holdings, Inc. (HRMY)

Harmony Biosciences Holdings, Inc. (HRMY) is a healthcare company (biotechnology) based in the United States. The share price is $33.01, up 0.15% on the day, which values the company at $1.94B. Price as of 18 Nov 2026, 12:18 UTC, from Yahoo Finance.

Key facts

Share price
$33.01+0.15% today
Market value
$1.94B
P/E ratio
10.9×last 12 months
Forward P/E
5.4×
Funk Score
91/100
Against its own history
Well below its usual priceusual price $61.11
200-week average
$33.963% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Harmony Biosciences Holdings, Inc. in more detail

HRMY trades at 10.9× its last twelve months' earnings, 5.4× next year's expected earnings, 2.0× sales. Measured against its own history, the price is 46% below what its usual multiples would imply ($61.11) — well below its usual price. It sits 3% below its 200-week average of $33.96.

Over the last five fiscal years Harmony Biosciences Holdings, Inc. has compounded revenue 40.3% a year. Its Funk Score is 91 out of 100 (financial strength 9.0, profitability 7.3, growth 10.0, value 10.0, each out of 10).

In its favour: Altman Z in the safe zone; Five straight years of revenue growth. Worth checking: Gross margin is shrinking.

Harmony Biosciences Holdings, Inc. (HRMY): questions and answers

What is HRMY's P/E ratio?

Harmony Biosciences Holdings, Inc. trades at 10.9× its last twelve months' earnings and 5.4× next year's expected earnings. At its fiscal year-ends over the past 5 years the P/E ranged from 13.7× to 73.5×, with a median of 15.2×.

What is Harmony Biosciences Holdings, Inc.'s market cap?

Harmony Biosciences Holdings, Inc. is valued at $1.94B at a share price of $33.01.

Is HRMY overvalued or undervalued?

Against its own history, HRMY is well below its usual price: the price is 46% below the $61.11 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is HRMY above its 200-week moving average?

No. HRMY is 2.8% below its 200-week average of $33.96. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Harmony Biosciences Holdings, Inc. growing?

Over the last five fiscal years Harmony Biosciences Holdings, Inc.'s revenue grew 40.3% a year.

Does HRMY pay a dividend?

Harmony Biosciences Holdings, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Harmony Biosciences Holdings, Inc. (HRMY) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/HRMY

Underlying data: Yahoo Finance; company filings with the SEC.